Harvest Bitcoin Spot ETF
03439
Bosera HashKey Bitcoin ETF
03008
ChinaAMC Bitcoin ETF
03042
CSOP Bitcoin Futures ETF
03066
Samsung Bitcoin Futures Active ETF
03135
HK Stock MarketDetailed Quotes
02500 VENUS MEDTECH-B
- 5.620
- 0.0000.00%
Not Open Dec 4 16:08 CST
2.48BMarket Cap-4040P/E (TTM)
0.000High0.000Low0Volume0.000Open5.620Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)441.01MShares5.94052wk High0.83P/B2.48BFloat Cap5.03052wk Low--Dividend TTM441.01MShs Float97.000Historical High--Dividend LFY0.00%Amplitude3.740Historical Low--Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
VENUS MEDTECH-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.74%230.72M | 20.89%491.37M | 21.74%255.61M | -2.26%406.46M | -12.25%209.97M | 50.65%415.86M | 134.46%239.27M | 18.34%276.05M | --102.05M | 102.23%233.27M |
| Operating income | -9.74%230.72M | 20.89%491.37M | 21.74%255.61M | -2.26%406.46M | -12.25%209.97M | 50.65%415.86M | 134.46%239.27M | 18.34%276.05M | 102.05M | 102.23%233.27M |
| Cost of sales | 9.94%-48.96M | -10.50%-102.17M | -18.72%-54.36M | -1.03%-92.46M | 10.53%-45.79M | -87.66%-91.52M | -201.74%-51.18M | -26.32%-48.77M | ---16.96M | -135.87%-38.61M |
| Operating expenses | 9.94%-48.96M | -10.50%-102.17M | -18.72%-54.36M | -1.03%-92.46M | 10.53%-45.79M | -87.66%-91.52M | -201.74%-51.18M | -26.32%-48.77M | -16.96M | -135.87%-38.61M |
| Gross profit | -9.68%181.76M | 23.95%389.21M | 22.58%201.25M | -3.19%314M | -12.71%164.18M | 42.71%324.34M | 121.05%188.09M | 16.75%227.28M | 85.09M | 96.67%194.67M |
| Selling expenses | 17.05%-130.99M | -15.40%-300.48M | -28.01%-157.91M | -20.51%-260.38M | -24.54%-123.36M | -60.56%-216.07M | -109.79%-99.05M | -8.03%-134.57M | ---47.22M | -86.30%-124.57M |
| Administrative expenses | 1.69%-76.58M | 19.98%-153.79M | -42.28%-77.89M | -49.46%-192.18M | -22.22%-54.75M | -23.56%-128.59M | -14.40%-44.79M | 47.34%-104.06M | ---39.16M | 11.73%-197.61M |
| Research and development expenses | 38.64%-180.83M | 0.48%-524.92M | -33.77%-294.72M | -104.17%-527.45M | -111.18%-220.32M | -54.46%-258.34M | -54.32%-104.33M | 16.60%-167.25M | ---67.61M | -91.39%-200.53M |
| Impairment and provision | 107.91%764K | 110.06%2.21M | -168.60%-9.66M | -589.86%-21.97M | -12.52%-3.6M | -6,470.00%-3.19M | -236.67%-3.2M | 102.30%50K | ---949K | -29.75%-2.17M |
| -Other impairment is provision | 107.91%764K | 110.06%2.21M | -168.60%-9.66M | -589.86%-21.97M | -12.52%-3.6M | -6,470.00%-3.19M | -236.67%-3.2M | 102.30%50K | ---949K | -29.75%-2.17M |
| Operating interest expense | ---- | ---- | ---- | ---- | -1,769.92%-18.4M | 54.34%-1.91M | 67.99%-984K | 80.97%-4.17M | ---3.07M | ---21.92M |
| Special items of operating profit | -59.34%2.74M | 82.31%-72.48M | -72.42%6.74M | -399.08%-409.79M | 152.61%24.43M | -2,128.83%-82.11M | -256.59%-46.43M | 87.47%-3.68M | --29.65M | -1,732.98%-29.41M |
| Operating profit | 38.85%-203.14M | 39.86%-660.24M | -43.30%-332.19M | -200.07%-1.1B | -109.43%-231.81M | -96.25%-365.84M | -155.84%-110.69M | 51.14%-186.41M | -43.26M | -28.73%-381.54M |
| Financing cost | 68.56%-9.81M | -40.55%-62.72M | ---31.19M | ---44.62M | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | -10.30%-10.87M | ---- | 15.88%-9.85M | -85.42%-12.1M | -2,154.56%-11.71M | -2,361.51%-6.52M | --570K | ---265K | ---- |
| Share of profit from joint venture company | 90.80%-641K | 62.98%-1.52M | -178.78%-6.96M | ---4.09M | ---2.5M | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 42.33%-213.58M | 36.41%-735.34M | -50.30%-370.34M | -206.27%-1.16B | -110.22%-246.41M | -103.16%-377.56M | -169.27%-117.21M | 51.29%-185.84M | -43.53M | -27.34%-381.54M |
| Tax | 15.32%4.76M | -81.68%6.28M | -38.79%4.12M | 456.76%34.3M | 168,550.00%6.74M | 107.09%6.16M | 55.56%-4K | 282.39%2.98M | ---9K | 186.64%778K |
| After-tax profit from continuing operations | 42.98%-208.83M | 35.02%-729.06M | -52.80%-366.22M | -202.12%-1.12B | -104.47%-239.67M | -103.09%-371.39M | -169.22%-117.22M | 51.97%-182.87M | -43.54M | -26.70%-380.77M |
| Earning after tax | 42.98%-208.83M | 35.02%-729.06M | -52.80%-366.22M | -202.12%-1.12B | -104.47%-239.67M | -103.09%-371.39M | -169.22%-117.22M | 51.97%-182.87M | -43.54M | -26.70%-380.77M |
| Minority profit | 85.41%-2.34M | 60.68%-25.3M | 59.67%-16.03M | -2,969.89%-64.34M | -857.01%-39.74M | 355.06%2.24M | -29,557.14%-4.15M | -1,992.86%-879K | ---14K | 56.70%-42K |
| Profit attributable to shareholders | 41.04%-206.49M | 33.46%-703.75M | -75.15%-350.19M | -183.08%-1.06B | -76.83%-199.93M | -105.31%-373.64M | -159.77%-113.06M | 52.20%-181.99M | -43.52M | -26.73%-380.72M |
| Basic earnings per share | 41.25%-0.47 | 33.47%-1.61 | -73.91%-0.8 | -184.71%-2.42 | -76.92%-0.46 | -88.89%-0.85 | -136.36%-0.26 | 63.11%-0.45 | -0.11 | -18.45%-1.22 |
| Diluted earnings per share | 41.25%-0.47 | 33.47%-1.61 | -73.91%-0.8 | -184.71%-2.42 | -76.92%-0.46 | -88.89%-0.85 | -136.36%-0.26 | 63.11%-0.45 | -0.11 | -18.45%-1.22 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhonghui Certified Public Accountants | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
